Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in (b)(4), kentucky.Alung technologies, inc.Received a report that during emergency use hemolung therapy, a catheter attempt was made.The first catheter attempt was of the right femoral artery.The femoral site was chosen due to location of existing dialysis catheter placement in right intrajugular.Arterial injury was suspected during final dilation, and the catheter was aborted to evaluate/treat the patient.Upon removal, the guidewire was found to be moderately kinked.The bleeding stopped and the vascular surgeon evaluated the patient with no hematoma or bleeding noted.Thus the catheter procedure was then continued.Following successful catheter, shortly after initiation of hemolung therapy, a low co2 removal alarm was observed on the controller.The physician increased the rpm settings on the controller to optimize the blood flow.The increased blood flow increased the co2 removal rate above the alarm threshold.The controller alarmed as appropriate in response to the rate.The data log from hemolung therapy has been retrieved and reviewed by both clinical and software engineering staff.No abnormalities were noted within the co2 removal and blood flow graphs.No unexpected alarms or errors occurred.Hemolung therapy was provided as intended.No capa was opened because of this event.Guidewire kinking is a known possible complication associated with the catheter process.Arterial injury is a known possible complication associated with the catheter process as well.Examination of the controller data log shows that hemolung therapy was provided as intended.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
|